Morphosys says takeover by Novartis on course after report of drug safety concern
Morphosys’ statement came after a report that cited two people familiar with the matter, of a safety issue with its experimental drug pelabresib, which is being developed to treat myelofibrosis, a rare type of blood cancer affecting the bone marrow.